Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study). (Q39187965)
Jump to navigation
Jump to search
scientific article published on 31 October 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study). |
scientific article published on 31 October 2016 |
Statements
1 reference
Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study). (English)
1 reference
Jérôme Fayette
1 reference
Lori Wirth
1 reference
Cristina Oprean
1 reference
Anghel Udrea
1 reference
Antonio Jimeno
1 reference
Danny Rischin
1 reference
Christopher Nutting
1 reference
Paul M Harari
1 reference
Tibor Csoszi
1 reference
Dana Cernea
1 reference
Paul O'Brien
1 reference
William D Hanley
1 reference
Amy V Kapp
1 reference
Maria Anderson
1 reference
Elicia Penuel
1 reference
Bruce McCall
1 reference
Andrea Pirzkall
1 reference
Jan B Vermorken
1 reference
31 October 2016
1 reference
1 reference
232
1 reference
Identifiers
1 reference
1 reference